Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 (multiple letters) [1]

Journal of the National Cancer Institute

Volumn 94, Issue 8, 2002, Pages 630-632

  Wojnowski, Leszek ^a,d   Hustert, Elisabeth ^a   Klein, Kathrin ^b   Goldammer, Mark ^e   Haberl, Michael ^a   Kirchheiner, Julia ^c   Koch, I N A ^a   Klattig, Jürgen ^a   Zanger, Ulrich ^b   Brockmöller, Jürgen ^e  

^a Epidauros Biotechnologie AG   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; CYTOCHROME P450 3A4; DNA; IRINOTECAN;

CANCER SUSCEPTIBILITY; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC LINKAGE; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LETTER; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE TUMOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ALLELES; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; GENETIC MARKERS; HUMANS; LIVER; MALE; MIXED FUNCTION OXYGENASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 0037123351     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)